Novartis has boosted its 2024 outlook for a second time this year, thanks to strong sales for some of its biggest drugs used to treat heart failure and other ailments.
Novartis lifts guidance again as demand climbs for top drugs
Read Next
- Speculator Bets led by SOFR 3-Months & 10-Year Bonds :: InvestMacro
- Speculator Bets led by S&P500 & Russell-2000 :: InvestMacro
- Men who grew up with temperamental and immature fathers usually display these 7 behaviors later in life
- People who become less intelligent as they get older usually display these 7 behaviors, according to psychology
- How macroeconomic indicators performed in November 2024?, ET BFSI
- IFC invests $75 mn in NDR InvIT’s sustainability-linked bonds, ET BFSI
- 8 signs you have a healthy relationship with your parents (even if it doesn’t always feel like it)
